scholarly article | Q13442814 |
P50 | author | Milagros C Rosal | Q85855135 |
Judith K. Ockene | Q113389547 | ||
Ira S. Ockene | Q113390764 | ||
Philip A Merriam | Q114515555 | ||
Yunsheng Ma | Q47257728 | ||
P2093 | author name string | Pritesh J Gandhi | |
P2860 | cites work | Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease. | Q51611276 |
Smoking cessation and severity of disease: the Coronary Artery Smoking Intervention Study | Q68120262 | ||
Facilitating dietary change: the patient-centered counseling model | Q73674394 | ||
Long-term persistence in use of statin therapy in elderly patients | Q74497691 | ||
Persistence of use of lipid-lowering medications: a cross-national study | Q74586986 | ||
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 | ||
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial | Q28214393 | ||
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | Q29547887 | ||
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines | Q29619614 | ||
Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels | Q29620696 | ||
Provider training for patient-centered alcohol counseling in a primary care setting | Q30233795 | ||
Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data | Q31048045 | ||
Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease | Q33611567 | ||
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q34595917 | ||
Dietary quality 1 year after diagnosis of coronary heart disease | Q36662790 | ||
Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. | Q37224119 | ||
Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial | Q38402228 | ||
Apparent discontinuation rates in patients prescribed lipid-lowering drugs. | Q39420320 | ||
Pharmacists' ability to influence outcomes of hypertension therapy | Q39439695 | ||
Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings? | Q40496473 | ||
Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT) Invest | Q40778873 | ||
Medication compliance: a healthcare problem | Q40859935 | ||
When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction | Q40900446 | ||
The assessment of refill compliance using pharmacy records: methods, validity, and applications | Q41361915 | ||
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. | Q45142621 | ||
Physician-pharmacist comanagement of hypertension: a randomized, comparative trial | Q46151910 | ||
Severity of angiographically proven coronary artery disease predicts smoking cessation | Q48871925 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | heart disease | Q190805 |
coronary artery disease | Q844935 | ||
P304 | page(s) | 383281 | |
P577 | publication date | 2010-08-17 | |
P1433 | published in | Cholesterol | Q26842087 |
P1476 | title | Randomized Trial of a Pharmacist-Delivered Intervention for Improving Lipid-Lowering Medication Adherence among Patients with Coronary Heart Disease | |
P478 | volume | 2010 |
Q28080044 | A Metaanalysis of Interventions to Improve Adherence to Lipid-Lowering Medication |
Q35788550 | A pharmacist-led follow-up program for patients with established coronary heart disease in North Norway - a randomized controlled trial. |
Q38232840 | Assessment of pharmacist-led patient counseling in randomized controlled trials: a systematic review. |
Q93184705 | Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States |
Q54561788 | Does hospitalization influence patients' medication adherence and community pharmacists' interventions? |
Q35965141 | Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease |
Q92480262 | Impact of pharmacy care upon adherence to cardiovascular medicines: a feasibility pilot controlled trial |
Q34547763 | Interventions to improve adherence to lipid-lowering medication. |
Q38774887 | Interventions to improve medication adherence in coronary disease patients: A systematic review and meta-analysis of randomised controlled trials. |
Q28066001 | Patient-Centered Interventions to Improve Adherence to Statins: A Narrative Synthesis of Systematically Identified Studies |
Q33568055 | The effect of telephone support interventions on coronary artery disease (CAD) patient outcomes during cardiac rehabilitation: a systematic review and meta-analysis |
Search more.